DNA X appoints Mike Mulica as acting CEO; salary $450k, 50k RSUs; CFO Crolius gets 35k RSUs

DNA X, Inc.

Mike Mulica appointed acting CEO effective Feb 9, 2026; base salary raised to $450,000 retroactive to Jan 30.
Mulica receives 50,000 RSUs vesting monthly over one year; COBRA reimbursement up to 12 months post-termination.
CFO Clay Crolius amendment acknowledges Jan 23 asset sale as a triggering event for change in control.
Crolius granted 35,000 RSUs vesting monthly over one year; COBRA reimbursement up to 6 months post-termination.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.